WallStreetZen

NASDAQ: ACAD
Acadia Pharmaceuticals Inc Stock

$20.60+0.17 (0.83%)
Updated Apr 13, 2021
ACAD Price
$20.60
Fair Value Price
N/A
Market Cap
$3.27B
52 Week Low
$20.12
52 Week High
$58.72
P/E
-11.51x
P/B
5.22x
P/S
19.04x
PEG
N/A
Dividend Yield
0%
Revenue
$441.76M
Earnings
-$281.58M
Gross Margin
97.7%
Operating Margin
-63.6%
Profit Margin
-63.7%
Debt to Equity
0.25
Operating Cash Flow
-$136M
Beta
1.06
Next Earnings
May 5, 2021
Ex-Dividend
N/A
Next Dividend
N/A

ACAD Overview

Zen Score

High
Medium
Low
30
Industry average

Reasons for this score

ACAD is good value based on its book value relative to its share price (5.22x), compared to the US market average (-0.01x)
Valuation
ACAD is good value based on its book value relative to its share price (5.22x), compared to the US Biotechnology industry average (0x)
Valuation
ACAD's cash and short-term investments ($637.73M) can cover ACAD's cash burn for the next year ($143.75M), even accounting for increasing cash burn (69.95%)
Financials

1 of 7

ACAD News

Valuation

ACAD fair value

Fair Value of ACAD stock based on Discounted Cash Flow (DCF)
Price
$20.60
Fair Value
$22.48
Undervalued by
8.35%

ACAD price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-11.51x
Industry
38.31x
Market
19.9x

ACAD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
5.22x
Industry
0x
Market
-0.01x
ACAD is good value based on its book value relative to its share price (5.22x), compared to the US market average (-0.01x)
Valuation
ACAD is good value based on its book value relative to its share price (5.22x), compared to the US Biotechnology industry average (0x)
Valuation

ACAD's financial health

Profit margin

Revenue
$121.0M
Net Income
-$66.8M
Profit Margin
-55.2%
ACAD's cash and short-term investments ($637.73M) can cover ACAD's cash burn for the next year ($143.75M), even accounting for increasing cash burn (69.95%)
Financials
ACAD's profit margin has increased (+5.7%) in the last year from (-69.4%) to (-63.7%), but it is still unprofitable
Financials

Assets to liabilities

Assets
$782.6M
Liabilities
$155.6M
Debt to equity
0.07
ACAD's short-term assets ($717.62M) exceed its short-term liabilities ($105.97M)
Financials
ACAD's short-term assets ($717.62M) exceed its long-term liabilities ($49.64M)
Financials
ACAD's debt has increased relative to shareholder equity (0.25), over the past 5 years ago (0.11)
Financials
ACAD's debt to equity ratio (0.25) is considered acceptable
Financials

Cash flow

Operating
-$27.5M
Investing
-$117.0M
Financing
$18.1M
ACAD's cash and short-term investments ($637.73M) can cover ACAD's cash burn ($143.75M) for at least 1 year
Financials

Acadia Pharmaceuticals Stock FAQ

What is Acadia Pharmaceuticals's quote symbol?

(NASDAQ: ACAD) Acadia Pharmaceuticals trades on the NASDAQ under the ticker symbol ACAD. Acadia Pharmaceuticals stock quotes can also be displayed as NASDAQ: ACAD.

What is the 52 week high and low for Acadia Pharmaceuticals (NASDAQ: ACAD)?

(NASDAQ: ACAD) Acadia Pharmaceuticals's 52-week high was $58.72, and its 52-week low was $20.12. It is currently -64.92% from its 52-week high and 2.39% from its 52-week low.

How much is Acadia Pharmaceuticals stock worth today?

(NASDAQ: ACAD) Acadia Pharmaceuticals currently has 158,978,087 outstanding shares. With Acadia Pharmaceuticals stock trading at $20.60 per share, the total value of Acadia Pharmaceuticals stock (market capitalization) is $3.27B.

Acadia Pharmaceuticals stock was originally listed at a price of $6.70 in May 27, 2004. If you had invested in Acadia Pharmaceuticals stock at $6.70, your return over the last 16 years would have been 207.46%, for an annualized return of 7.27%.

How much is Acadia Pharmaceuticals's stock price per share?

(NASDAQ: ACAD) Acadia Pharmaceuticals stock price per share is $20.60 today (as of Apr 13, 2021).

What is Acadia Pharmaceuticals's Market Cap?

(NASDAQ: ACAD) Acadia Pharmaceuticals's market cap is $3.27B, as of Apr 15, 2021.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Acadia Pharmaceuticals's market cap is calculated by multiplying ACAD's current stock price of $20.60 by ACAD's total outstanding shares of 158,978,087.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.